ClinicalTrialExchange
  • Home
  • For Patients
  • For Professionals
  • About
  • Contact

Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Fibrous Dysplasia of Bone

  • Burosumab for Fibroblast Growth Factor-23 Mediated Hypophosphatemia in Fibrous Dysplasia
  • A Phase 2 Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia
  • Denosumab Treatment for Fibrous Dysplasia
  • TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE
  • Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
  • A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
  • Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
  • Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
  • Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies

Clinical Trials data from clinicaltrials.gov

Powered by DrugPatentWatch.

  • About
  • Contact
  • Follow ClinicalTrialsExchange:

      ClinicalTrialsExchange Linkedin Group